TEVA AGAIN HIKES COPAXONE PRICES

Amtech investment house pointed out today a 4% increase in the price of Copaxone, the flagship drug of Israeli pharmaceutical giant Teva Pharmaceutical Industries Ltd. The price hike will apparently boost Tevs's results for the third quarter of this year. Globes (http://www.globes.co.il/serveen/globes/DocView.asp?did=1000125536&fid=1725)